anchor instance (Q86406)

From ScienceSource
Jump to: navigation, search
No description defined
edit
Language Label Description Also known as
English
anchor instance
No description defined

    Statements

    important contributor to lipid-related residual risk, especially in insulin resistant conditions such as
    0 references
    . Current therapeutic options include peroxisome proliferator-activated receptor alpha (PPARα) agonists,
    0 references
    no value
    0 references
    7
    0 references
    714
    0 references
    16 April 2019
    0 references
    0 references
    Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia. (5628452)
    0 references
    no value
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit